Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 4379807
[patent_doc_number] => 06294341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-25
[patent_title] => 'Method for detecting a substance having an activity to inhibit HIV infection using immunoassay and variant protein used for said method'
[patent_app_type] => 1
[patent_app_number] => 9/272342
[patent_app_country] => US
[patent_app_date] => 1999-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 6515
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/294/06294341.pdf
[firstpage_image] =>[orig_patent_app_number] => 272342
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/272342 | Method for detecting a substance having an activity to inhibit HIV infection using immunoassay and variant protein used for said method | Mar 18, 1999 | Issued |
Array
(
[id] => 4337456
[patent_doc_number] => 06333303
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Antiviral ricin-like proteins'
[patent_app_type] => 1
[patent_app_number] => 9/147208
[patent_app_country] => US
[patent_app_date] => 1999-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 35
[patent_no_of_words] => 24763
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333303.pdf
[firstpage_image] =>[orig_patent_app_number] => 147208
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147208 | Antiviral ricin-like proteins | Mar 1, 1999 | Issued |
Array
(
[id] => 3942167
[patent_doc_number] => 05998132
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Method and apparatus for detecting cancer, influenza, or HIV based on .alpha.-N-acetyl-galactosaminidase detection'
[patent_app_type] => 1
[patent_app_number] => 9/245755
[patent_app_country] => US
[patent_app_date] => 1999-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3976
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998132.pdf
[firstpage_image] =>[orig_patent_app_number] => 245755
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/245755 | Method and apparatus for detecting cancer, influenza, or HIV based on .alpha.-N-acetyl-galactosaminidase detection | Feb 7, 1999 | Issued |
Array
(
[id] => 4217545
[patent_doc_number] => 06040137
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Antigen/antibody specification exchanger'
[patent_app_type] => 1
[patent_app_number] => 9/246258
[patent_app_country] => US
[patent_app_date] => 1999-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6404
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040137.pdf
[firstpage_image] =>[orig_patent_app_number] => 246258
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/246258 | Antigen/antibody specification exchanger | Feb 7, 1999 | Issued |
Array
(
[id] => 638002
[patent_doc_number] => 07125957
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-24
[patent_title] => 'VPR mutant protein and its encoding gene having apoptosis-inducing action'
[patent_app_type] => utility
[patent_app_number] => 09/787437
[patent_app_country] => US
[patent_app_date] => 1999-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2668
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125957.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787437
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787437 | VPR mutant protein and its encoding gene having apoptosis-inducing action | Jan 28, 1999 | Issued |
Array
(
[id] => 4096826
[patent_doc_number] => 06048705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Sandwich immunoassays for collagen type I degradation products'
[patent_app_type] => 1
[patent_app_number] => 9/237176
[patent_app_country] => US
[patent_app_date] => 1999-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 12798
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048705.pdf
[firstpage_image] =>[orig_patent_app_number] => 237176
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/237176 | Sandwich immunoassays for collagen type I degradation products | Jan 24, 1999 | Issued |
09/232186 | METHOD OF PRODUCING VACCINES FROM PROTEIN SIGNAL OLIGOPEPTIDES | Jan 13, 1999 | Abandoned |
Array
(
[id] => 4067796
[patent_doc_number] => 06068851
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-30
[patent_title] => 'Formulation for use in the prevention of pathogen induced diseases including HIV and HSV'
[patent_app_type] => 1
[patent_app_number] => 9/051300
[patent_app_country] => US
[patent_app_date] => 1999-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6020
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/068/06068851.pdf
[firstpage_image] =>[orig_patent_app_number] => 051300
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/051300 | Formulation for use in the prevention of pathogen induced diseases including HIV and HSV | Jan 12, 1999 | Issued |
Array
(
[id] => 4137404
[patent_doc_number] => 06060236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Borna disease virus-specific DNA and proteins'
[patent_app_type] => 1
[patent_app_number] => 9/222227
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 5290
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060236.pdf
[firstpage_image] =>[orig_patent_app_number] => 222227
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222227 | Borna disease virus-specific DNA and proteins | Dec 28, 1998 | Issued |
Array
(
[id] => 1347297
[patent_doc_number] => 06583109
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-24
[patent_title] => 'Therapeutic polypeptides from -hCG and derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/220415
[patent_app_country] => US
[patent_app_date] => 1998-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 94
[patent_no_of_words] => 61167
[patent_no_of_claims] => 102
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/583/06583109.pdf
[firstpage_image] =>[orig_patent_app_number] => 09220415
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/220415 | Therapeutic polypeptides from -hCG and derivatives | Dec 23, 1998 | Issued |
09/219551 | IMMUNOLOGICAL METHOD OF ASSAYING ANTIBODIES TO TYPE II COLLAGEN IN HUMAN SERUM FOR DIAGNOSIS OF CLINICAL RHEUMATOID ARTHRITIS | Dec 21, 1998 | Abandoned |
Array
(
[id] => 4081497
[patent_doc_number] => 06017537
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Formyl methionyl peptide vaccine adjuvant'
[patent_app_type] => 1
[patent_app_number] => 9/216702
[patent_app_country] => US
[patent_app_date] => 1998-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5662
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/017/06017537.pdf
[firstpage_image] =>[orig_patent_app_number] => 216702
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/216702 | Formyl methionyl peptide vaccine adjuvant | Dec 17, 1998 | Issued |
Array
(
[id] => 4126083
[patent_doc_number] => 06146627
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody'
[patent_app_type] => 1
[patent_app_number] => 9/211156
[patent_app_country] => US
[patent_app_date] => 1998-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 12716
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/146/06146627.pdf
[firstpage_image] =>[orig_patent_app_number] => 211156
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/211156 | Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody | Dec 13, 1998 | Issued |
Array
(
[id] => 4006553
[patent_doc_number] => 05962236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Urinary assay for measuring bone resorption'
[patent_app_type] => 1
[patent_app_number] => 9/209864
[patent_app_country] => US
[patent_app_date] => 1998-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6240
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962236.pdf
[firstpage_image] =>[orig_patent_app_number] => 209864
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209864 | Urinary assay for measuring bone resorption | Dec 10, 1998 | Issued |
Array
(
[id] => 4149608
[patent_doc_number] => 06103268
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-15
[patent_title] => 'Administering osmotic colonic evacuant containing a picosulfate'
[patent_app_type] => 1
[patent_app_number] => 9/200781
[patent_app_country] => US
[patent_app_date] => 1998-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3707
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/103/06103268.pdf
[firstpage_image] =>[orig_patent_app_number] => 200781
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/200781 | Administering osmotic colonic evacuant containing a picosulfate | Nov 29, 1998 | Issued |
09/198889 | MONOCLONAL HUMAN NATURAL ANTIBODIES | Nov 23, 1998 | Abandoned |
Array
(
[id] => 4236317
[patent_doc_number] => 06090621
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-18
[patent_title] => 'Signaling inositol polyphosphate 5-phosphatases (SIPs)'
[patent_app_type] => 1
[patent_app_number] => 9/195868
[patent_app_country] => US
[patent_app_date] => 1998-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 1
[patent_no_of_words] => 41368
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/090/06090621.pdf
[firstpage_image] =>[orig_patent_app_number] => 195868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/195868 | Signaling inositol polyphosphate 5-phosphatases (SIPs) | Nov 18, 1998 | Issued |
Array
(
[id] => 4202770
[patent_doc_number] => 06027731
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Pertussis toxin induced lymphocytosis'
[patent_app_type] => 1
[patent_app_number] => 9/193654
[patent_app_country] => US
[patent_app_date] => 1998-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 10
[patent_no_of_words] => 5954
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/027/06027731.pdf
[firstpage_image] =>[orig_patent_app_number] => 193654
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/193654 | Pertussis toxin induced lymphocytosis | Nov 16, 1998 | Issued |
Array
(
[id] => 4140269
[patent_doc_number] => 06030792
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Assays for measurement of protein fragments in biological media'
[patent_app_type] => 1
[patent_app_number] => 9/184658
[patent_app_country] => US
[patent_app_date] => 1998-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28456
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/030/06030792.pdf
[firstpage_image] =>[orig_patent_app_number] => 184658
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/184658 | Assays for measurement of protein fragments in biological media | Nov 1, 1998 | Issued |
Array
(
[id] => 4236702
[patent_doc_number] => 06080539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-27
[patent_title] => 'In situ immunodetection of antigens'
[patent_app_type] => 1
[patent_app_number] => 9/168209
[patent_app_country] => US
[patent_app_date] => 1998-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 6197
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/080/06080539.pdf
[firstpage_image] =>[orig_patent_app_number] => 168209
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/168209 | In situ immunodetection of antigens | Oct 6, 1998 | Issued |